Current perspectives in the application of medicinal plants against cancer: novel therapeutic agents

S Gezici, N Şekeroğlu - Anti-Cancer Agents in Medicinal …, 2019 - ingentaconnect.com
Background: Cancer is a disease characterized by uncontrolled cell growth and
proliferation. It has become a major health problem in the past decades and is now the …

Natural products as leads to anticancer drugs

M Gordaliza - Clinical and Translational Oncology, 2007 - Springer
Throughout history, natural products have afforded a rich source of compounds that have
found many applications in the fields of medicine, pharmacy and biology. Within the sphere …

Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple roles

JW Kenney, CE Moore, X Wang, CG Proud - Advances in biological …, 2014 - Elsevier
Eukaryotic elongation factor 2 kinase (eEF2K) is a member of the small group of atypical 'α-
kinases'. It phosphorylates and inhibits eukaryotic elongation factor 2, to slow down the …

[HTML][HTML] The translation elongation factor eEF2 is a novel tumor‑associated antigen overexpressed in various types of cancers

Y Oji, N Tatsumi, M Fukuda… - International …, 2014 - spandidos-publications.com
Recent studies have shown that cancer immunotherapy could be a promising therapeutic
approach for the treatment of cancer. In the present study, to identify novel tumor-associated …

Doxorubicin exerts cytotoxic effects through cell cycle arrest and Fas-mediated cell death

HS Kim, YS Lee, DK Kim - Pharmacology, 2009 - karger.com
Doxorubicin (DOX) is involved in the induction of DNA damage, inhibition of cell
proliferation, impairment of mitochondria, and cell death. To determine the biological effects …

The alpha-kinase family: an exceptional branch on the protein kinase tree

J Middelbeek, K Clark, H Venselaar… - Cellular and molecular …, 2010 - Springer
The alpha-kinase family represents a class of atypical protein kinases that display little
sequence similarity to conventional protein kinases. Early studies on myosin heavy chain …

[HTML][HTML] The role of protein synthesis in cell cycling and cancer

S White-Gilbertson, DT Kurtz, C Voelkel-Johnson - Molecular oncology, 2009 - Elsevier
Cell cycling and protein synthesis are both key physiological tasks for cancer cells. Here we
present a model for how the elongation phase of protein synthesis, governed by elongation …

Natural products as lead compounds in drug discovery

J Khazir, BA Mir, SA Mir, D Cowan - 2013 - Taylor & Francis
This review surveys the diversity of natural products (NPs) derived from terrestrial plants,
micro-organisms, marine organisms and fungi used in the treatment of various diseases. A …

Dihydroartemisinin enhances Apo2L/TRAIL-mediated apoptosis in pancreatic cancer cells via ROS-mediated up-regulation of death receptor 5

R Kong, G Jia, Z Cheng, Y Wang, M Mu, S Wang… - PloS one, 2012 - journals.plos.org
Background Dihydroartemisinin (DHA), a semi-synthetic derivative of artemisinin, has
recently shown antitumor activity in various cancer cells. Apo2 ligand or tumor necrosis …

Doxorubicin sensitizes human tumor cells to NK cell‐and T‐cell‐mediated killing by augmented TRAIL receptor signaling

E Wennerberg, D Sarhan, M Carlsten… - … journal of cancer, 2013 - Wiley Online Library
Doxorubicin (DOX) is an anthracycline antibiotic that is widely used to treat different types of
malignancy. In this study, it was studied whether DOX could be used to render tumor cells …